Cargando…
Interleukin-1β weakens paclitaxel sensitivity through regulating autophagy in the non-small cell lung cancer cell line A549
Non-small cell lung cancer (NSCLC) poses a threat to human health and paclitaxel chemotherapy has been approved for the treatment of this type of cancer. However, resistance to treatment severely compromises the survival rate and prognosis of patients with NSCLC. The aim of the present study was to...
Autores principales: | Lian, Juanwen, Hua, Tao, Xu, Jialing, Ding, Jie, Liu, Zejie, Fan, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885084/ https://www.ncbi.nlm.nih.gov/pubmed/33717236 http://dx.doi.org/10.3892/etm.2021.9724 |
Ejemplares similares
-
Coiled-coil domain-containing 68 promotes non-small cell lung cancer cell proliferation in vitro
por: Hua, Tao, et al.
Publicado: (2020) -
Targeted paclitaxel‐octreotide conjugates inhibited the growth of paclitaxel‐resistant human non‐small cell lung cancer A549 cells in vitro
por: Liu, Yanguo, et al.
Publicado: (2021) -
Overexpression of A613T and G462T variants of DNA polymerase β weakens chemotherapy sensitivity in esophageal cancer cell lines
por: Wang, Yuanyuan, et al.
Publicado: (2016) -
Altered Mitochondrial Dynamics, Biogenesis, and Functions in the Paclitaxel-Resistant Lung Adenocarcinoma Cell Line A549/Taxol
por: Zhou, Xiang, et al.
Publicado: (2020) -
Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells
por: Klimaszewska-Wiśniewska, Anna, et al.
Publicado: (2018)